satralizumab

Spain

Drugs containing this active substance

  • ENSPRYNG 120 MG SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE

    It is used to treat neuromyelitis optica spectrum disorder (NMOSD) in adults and adolescents aged 12 years and older. This disease affects the optic nerves and the spinal cord due to a malfunction of the immune system.

    Form: solution for injection in a pre-filled syringe

    Active substance Dosage
    satralizumab 120 mg

    ATC: L04A L04AC L04AC19

    Manufacturer: Roche Registration Gmbh